Help your patients access digital gut-directed hypnotherapy - with proven outcomes, no waitlists, and no added work for you.
IBS is classified as a disorder of gut-brain interaction (DGBI) – highlighting the need for integrated care.
Evidence shows combining medical, dietary, and behavioral interventions delivers the best patient outcomes.1
Although gut-directed hypnotherapy is recommended by clinical practice guidelines, limited access to GI psychotherapy leads to 6+ month long waitlists and a critical gap in behavioral management.
A randomized controlled trial of 244 participants demonstrated clinically significant improvements in symptom management with Nerva.2
Explore more research
Fill out your details to connect with our team, request a lunch & learn for your clinic, or get free access as a practitioner.
Contact usThe Nerva program costs $199 USD, $249 AUD, €229 EUR or £149 GBP for 12 months of access. However, patients referred by their healthcare practitioner receive a 25% discount.
Patients begin with a 7-day free trial to explore the program risk-free. For added peace of mind, we also offer a 42-day money-back guarantee.
Nerva is designed for patients with IBS, including those with constipation (IBS-C), diarrhea (IBS-D), or mixed (IBS-M) subtypes. It is particularly beneficial for patients experiencing stress and/or anxiety, those seeking non-pharmacological or non-dietary interventions, and refractory patients who have not responded to other treatments.
Contraindications: Nerva is not recommended for individuals with severe psychiatric disorders, unresolved psychological trauma, or cognitive impairments.
For an in-depth guide, see our decision tool.
Gut-directed hypnotherapy (GDH) is a psychological therapy that helps regulate the gut-brain connection. It guides individuals into a state of focused attention, where individuals become more receptive to therapeutic suggestions. This heightened state of awareness helps regulate the gut-brain connection, easing IBS symptoms by shifting the body out of a stress response and into a state of calm.
During hypnosis, we can observe physiological changes in brain activity related to absorption, executive control, and awareness.
With self-hypnosis, patients can access these benefits anytime, anywhere – without the need for an in-person hypnotherapist – while remaining in complete control.
Yes, patients can choose to add your details, allowing you to receive progress updates and reports, including IBS-SSS and PHQ-4 symptom tracking. These insights are securely delivered through our HIPAA-compliant and Australian Privacy Principles-compliant reporting system.
Nerva is specifically designed for diagnosed IBS, targeting the gut-brain connection through gut-directed hypnotherapy (GDH). While research supports the effectiveness of GDH for IBS, some patients with other disorders of gut-brain interaction (DGBIs), such as functional dyspepsia, may still benefit. However, as Nerva is not tailored for these conditions, we recommend patients consult their healthcare provider to determine the best approach for their needs.
Yes, we offer free clinician access, allowing you to explore the full Nerva program firsthand. This gives you insight into the structure, content, and experience your patients will have.
Nerva follows a clinically-based 6-week program designed to improve IBS symptom management through gut-directed hypnotherapy.
To support long-term symptom management, patients receive a 12-month subscription – which includes ongoing access to our flare-up toolkit for maintenance and support whenever they need it.
Here is a smart phrase template that's worked well for other practices when adding Nerva to discharge instructions:
I’m referring you to Nerva, a clinically validated gut-directed hypnotherapy program designed to help you manage IBS symptoms. Most patients see results within 6 weeks.
Visit: www.nervahealth.com
1. Chey, W. D., Keefer, L., Whelan, K., & Gibson, P. R. (2020). Behavioral and Diet Therapies in Integrated Care for Patients with Irritable Bowel Syndrome. Gastroenterology, 160(1). https://doi.org/10.1053/j.gastro.2020.06.099
2. Anderson, Ellen J. BNutSci, MDiet1,2; Peters, Simone L. BSc (Psychophysiology) (Hons), PhD1; Gibson, Peter R. MBBS(Hons), MD1,2; Halmos, Emma P. BNutDiet, PGradDipBSc, PhD1,2. Comparison of Digitally Delivered Gut-Directed Hypnotherapy Program With an Active Control for Irritable Bowel Syndrome. The American Journal of Gastroenterology 120(2):p 440-448, February 2025. | DOI: 10.14309/ajg.0000000000002921
3. Peters, S. L., Yao, C. K., Philpott, H., Yelland, G. W., Muir, J. G., & Gibson, P. R. (2016). Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Alimentary pharmacology & therapeutics, 44(5), 447–459. https://doi.org/10.1111/apt.13706
